News Releases News Releases IR Sub Menu - News & Events News ReleasesEvents & Presentations News Releases Year None202220212020201920182017201620152014 Pear Therapeutics to Participate in LifeSci Partners HealthTech Symposium September 13, 2022 Pear Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference September 7, 2022 South Carolina Department of Corrections and Pear Therapeutics Team up to Support Inmates in Recovery from Substance Use Disorders September 1, 2022 Pear Therapeutics to Participate in Citi’s 17th Annual BioPharma Conference August 31, 2022 Pear Therapeutics Reports Second Quarter 2022 Results August 11, 2022 Pear Therapeutics Announces Publication of New Analysis of Real-World Data Showing Reduction in Insomnia Severity, Healthcare Resource Utilization and Associated Costs in Adults Using Somryst® August 10, 2022 Pear Therapeutics and SelectHealth Announce Coverage to Provide Access to FDA-Authorized Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder August 8, 2022 Pear Therapeutics and Cove Behavioral Health to Provide Patients Access to Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder August 3, 2022 Pear Therapeutics to be Added to Russell US Index Series August 2, 2022 Pear Therapeutics to Issue Second Quarter 2022 Financial Results on Thursday, August 11, 2022 July 28, 2022 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page next › Last page last » Displaying 1 - 10 of 42
News Releases Year None202220212020201920182017201620152014 Pear Therapeutics to Participate in LifeSci Partners HealthTech Symposium September 13, 2022 Pear Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference September 7, 2022 South Carolina Department of Corrections and Pear Therapeutics Team up to Support Inmates in Recovery from Substance Use Disorders September 1, 2022 Pear Therapeutics to Participate in Citi’s 17th Annual BioPharma Conference August 31, 2022 Pear Therapeutics Reports Second Quarter 2022 Results August 11, 2022 Pear Therapeutics Announces Publication of New Analysis of Real-World Data Showing Reduction in Insomnia Severity, Healthcare Resource Utilization and Associated Costs in Adults Using Somryst® August 10, 2022 Pear Therapeutics and SelectHealth Announce Coverage to Provide Access to FDA-Authorized Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder August 8, 2022 Pear Therapeutics and Cove Behavioral Health to Provide Patients Access to Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder August 3, 2022 Pear Therapeutics to be Added to Russell US Index Series August 2, 2022 Pear Therapeutics to Issue Second Quarter 2022 Financial Results on Thursday, August 11, 2022 July 28, 2022 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page next › Last page last » Displaying 1 - 10 of 42